2367:HKEXGiant Biogene Holding Co., Ltd. Analysis
Data as of 2026-09-05 - not real-time
HK$26.62
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
At HKD 26.62, Giant Biogene Holding Co., Ltd. shows a bearish moving-average alignment, with shorter averages beneath longer ones. Over a rolling month the price has lost 7.9%. Momentum indicators put RSI at 43.3 (neutral) with MACD reading bearish. Watch HKD 25.58 as support and HKD 30.48 as the nearer resistance level.
The shares look undervalued at 14.5 times earnings, though no sector average was available for comparison. Analyst price targets sit 49.8% above the current price. Revenue is contracting at 6.3% on a 31.4% profit margin. The 2.41% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 44.0%, a beta of 0.24 and a maximum drawdown of 61.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 3 out of 10.
The shares look undervalued at 14.5 times earnings, though no sector average was available for comparison. Analyst price targets sit 49.8% above the current price. Revenue is contracting at 6.3% on a 31.4% profit margin. The 2.41% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 44.0%, a beta of 0.24 and a maximum drawdown of 61.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 3 out of 10.
Top Market Events
Detailed price information for North State Telecommunications C NORSB from The Globe and Mail including charting and...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 30.96
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 30.96
- Analyst targets imply +49.8% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Analyst targets imply +49.8% versus the current price
- Profit margin of 31.4% is healthy
- Revenue contracting at -6.3%
Key Metrics & Analysis
Financial Health
Revenue Growth-6.30%
Profit Margin31.42%
P/E Ratio14.5
ROE18.01%
ROA9.80%
Debt/Equity0.13
P/B Ratio2.6
Technical Analysis
TrendBearish
RSI43.3
SupportHK$25.58
ResistanceHK$30.48
MA 20HK$27.80
MA 50HK$28.01
MA 200HK$30.96
MACDBearish
VolumeDecreasing
Fear & Greed Index95.48
Valuation
Target PriceHK$39.88
Upside/Downside49.81%
GradeUndervalued
TypeValue
Dividend Yield2.41%
Risk Assessment
Beta0.24
Volatility44.01%
Sector RiskLow
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.